Novo Nordisk reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Novo Nordisk using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-05 | $1.03 | $0.77 | 33.4 % |
| Q2 | 2025-08-06 | $0.91 | $0.93 | -2.15 % |
| Q1 | 2025-05-07 | $0.92 | $0.90 | 2.22 % |
| Q4 | 2025-02-05 | $0.91 | $0.83 | 9.64 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-05 | $11.75B | $11.88B | -1.14 % |
| Q2 | 2025-08-06 | $11.68B | $11.79B | -0.95 % |
| Q1 | 2025-05-07 | $10.89B | $11.64B | -6.44 % |
| Q4 | 2025-02-05 | $12.26B | $11.34B | 8.10 % |
Novo Nordisk (NVO) is scheduled to report earnings on February 4, 2026. The last reported earnings were for reported on November 5, 2025 for Q3.
The Actual EPS was $1.03, which beat the estimate of $0.77.
The Actual Revenue was $11.7B, which missed the estimate of $11.9B.
Browse earnings estimates, EPS, and revenue on all stocks.